Yahoo
    Shanghai - Delayed Quote CNY

    Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SS)

    85.10 -2.37 (-2.71%)
    At close: 3:00:02 PM GMT+8
    Chart Range Bar
    Advanced Chart
    AlphaSpace Chart
    Loading chart for 688578.SS
    • Previous Close 87.47
    • Open 88.56
    • Bid 85.10 x --
    • Ask 85.11 x --
    • Day's Range 85.01 - 88.57
    • 52 Week Range 75.55 - 138.30
    • Volume 5,105,425
    • Avg. Volume 7,569,870
    • Market Cap (intraday) 38.295B
    • Beta (5Y Monthly) 0.23
    • PE Ratio (TTM) 13.17
    • EPS (TTM) 6.46
    • Earnings Date --
    • Forward Dividend & Yield 1.20 (1.37%)
    • 1y Target Est --
    • Moby Rating Neutral

    Shanghai Allist Pharmaceuticals Co., Ltd., a pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally. The company's lead product is vometinib mesylate tablet for the treatment of patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer (NSCLC). It also develops pralatinib capsules, as well as glerexyl citrate tablets for treating adult patients with locally advanced or metastatic NSCLC. The company was founded in 2004 and is based in Shanghai, China.

    www.allist.com.cn

    1,989

    Full Time Employees

    December 31

    Fiscal Year Ends

    Healthcare

    Sector

    Biotechnology

    Industry

    More about Shanghai Allist Pharmaceuticals Co., Ltd.

    Recent News

    View More
    View More

    Performance Overview

    Trailing total returns as of 11/9/2026, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

    YTD Return

    688578.SS
    17.28%
    SSE Composite Index (000001.SS)
    7.76%

    1-Year Return

    688578.SS
    14.70%
    SSE Composite Index (000001.SS)
    8.42%

    3-Year Return

    688578.SS
    131.68%
    SSE Composite Index (000001.SS)
    19.90%

    5-Year Return

    688578.SS
    146.49%
    SSE Composite Index (000001.SS)
    4.39%

    Analyst Insights

    View More

    Analyst Recommendations

    • Strong Buy
    • Buy
    • Hold
    • Underperform
    • Sell
    View More

    Statistics

    View More

    Valuation Measures

    Annual

    • Market Cap

    • Enterprise Value

    • Trailing P/E

    • Forward P/E

    • PEG Ratio (current)

    • Price/Sales (ttm)

    • Price/Book (mrq)

    • Enterprise Value/Revenue

    • Enterprise Value/EBITDA

    Financial Highlights

    Profitability and Income Statement

    • Profit Margin

      44.11%

    • Return on Assets (ttm)

      22.65%

    • Return on Equity (ttm)

      37.63%

    • Revenue (ttm)

      6.59B

    • Net Income Avi to Common (ttm)

      2.91B

    • Diluted EPS (ttm)

      6.46

    Balance Sheet and Cash Flow

    • Total Cash (mrq)

      3.8B

    • Total Debt/Equity (mrq)

      0.04%

    • Levered Free Cash Flow (ttm)

      1.8B

    View More

    Company Insights

    Research Reports

    View More
    View More

    People Also Watch

    688506.SS Sichuan Biokin Pharmaceutical Co.,Ltd.
    266.44 +0.84%
    688266.SS Suzhou Zelgen Biopharmaceuticals Co., Ltd.
    90.21 -0.65%
    688321.SS Shenzhen Chipscreen Biosciences Co., Ltd.
    21.00 -0.57%
    688180.SS Shanghai Junshi Biosciences Co., Ltd.
    30.96 +0.36%
    688336.SS Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd
    33.16 -0.33%
    Mobilize your Website
    View Site in Mobile | Classic
    Share by: